Feb 23, 2017 09:10 PM IST
As many as 634 drugs of various
strengths produced by firms, including Cipla, Abbott,
Astrazeneca and Dr Reddy's, are "suspected" to be
non-compliant with ceiling prices as notified by NPPA.
- Dec 13, 2016 08:01 AM IST
Axis Bank | Tata Motors | Sun Pharma | IRB Infrastructure | Sunteck Realty | NIIT | Fortis Healthcare | Abbot India | APL Apollo Tubes | Aarey Drugs | PAE | MEP Infra and Bajaj Finance are stocks, which are in the news today.
- Nov 28, 2016 08:01 AM IST
Bharti Airtel | Cipla | GAIL | Idea Cellular | Apollo Tyres | Tata Elxsi | Aurobindo Pharma | Uflex | Dilip Buildcon | ARSS Infra | GPT Infra | Strides Shasun | Ashok Leyland and Ricoh India are stocks, which are in the news today.
- Mar 17, 2016 10:45 AM IST
Kewal Handa, industry expert and former MD of Pfizer says that alongwith sales loss, companies will also have to bear brunt of inventory loss as the decision has been immediate.
- Mar 17, 2016 08:31 AM IST
Here are the stocks that are likely to be in focus in today's trade
- Mar 15, 2016 07:46 PM IST
The Delhi HC has asked the government to explain its position and actions of issuing the March 10 notification. It has also stayed the notification with respect to Abbott and MacLeod and the stay will be in operation until next hearing on March 21.
- Mar 14, 2016 09:18 AM IST
Hailing the government's move, Surajit Pal, pharma analyst at Prabhudas Lilladher, says the aim of regulation is to prevent rampant use of antibiotics. He says Abbott is likely to be severely impacted by the move as it has around 15.4 percent exposure to fixed-dosed combinations.
- Mar 14, 2016 08:44 AM IST
Pharma companies such as Pfizer, Abbott, Glenmark and Wockhardt are likely to be in focus with the government banning over 300 drugs
- Oct 13, 2015 04:36 PM IST
Mehraboon Irani of Nirmal Bang Securities is of the view that Dr Reddy's Labs is the top pick.
- Sep 30, 2015 12:04 PM IST
The project was being developed for Jet Airways on a 50:50 profit-sharing agreement.
- Sep 16, 2015 12:28 PM IST
Godrej Properties is developing the BKC project for Jet Airways on a 50:50 sharing agreement.
- Jul 30, 2015 04:43 PM IST
Mehraboon Irani of Nirmal Bang Securities is positively biased in Dr Reddy's Laboratories.
- Jul 24, 2015 03:46 PM IST
In an interview with CNBC-TV18‘s Sonia Shenoy & Latha Venkatesh, Praful Bohra, VP- Research, Religare said that Lupin‘s numbers are weak due to decline in the US business.
- Nov 24, 2014 04:29 PM IST
Market expert Ambareesh Baliga believes market will move up over the next four-five days or one week. According to him, the appetite for such market is quite high as investors and traders are making a lot of money now.
- Aug 22, 2014 10:55 AM IST
Vishal Jajoo, of Nirmal Bang Commodities is of the view that one can buy Abbott India on correction.
- Jan 03, 2014 10:53 AM IST
Ramesh Damani, member, BSE said the undertone of the market was quite strong, and there was every reason to be optimistic.
- Jul 30, 2012 10:32 AM IST
Accumulate Abbott India, says Aashish Tater, Head of Research, Fort Share Broking.
- Jun 10, 2011 05:22 PM IST
Abbott India looks good, says Ganesh Shanbhag, CEO, SMS Financial Services.